Alirocumab

Red

Brand Name(s):Praluent

Indication:Hypercholesterolaemia- primary (heterozygous familial and non-familial), Mixed dyslipidaemia, as an adjunct to diet

Established atherosclerotic cardiovascular disease

Rationale:1,2,3

Considered:Sep-15

Review Date:Apr-24

Comments:
NICE TA 393 Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia June 2016